A randomized Southwest Oncology Group study comparing dexamethasone (D) to lenalidomide + dexamethasone (LD) as treatment of newly-diagnosed multiple myeloma (NDMM): Impact of cytogenetic abnormalities on efficacy of LD, and updated overall study results

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 8521
Main Authors:	Zonder, J. A., Crowley, J. J., Bolejack, V., Hussein, M. A., Moore, D. F., Whittenberger, B. F., Abidi, M. H., Durie, B. G., Barlogie, B.
Format:	Journal Article
Language:	English
Published:	20-05-2008
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!